Know What's Happening in HealthTech

In the Clinic for Feb. 20, 2026
NewsFeb 20, 2026

In the Clinic for Feb. 20, 2026

The February 20 2026 "In the Clinic" roundup aggregates a broad set of industry snapshots, special reports, and infographics covering biopharma, medical technology, and emerging research areas. It links to data on mRNA vaccine research, China’s GLP‑1 market, pulsed‑field ablation for atrial...

By BioWorld (Citeline) – Featured Feeds
AI Tool Sets New Standard in Diagnosing Rare Diseases
BlogFeb 20, 2026

AI Tool Sets New Standard in Diagnosing Rare Diseases

A new multi‑agent system called DeepRare, built on the DeepSeek‑V3 large language model and over 40 specialized tools, outperformed 15 competing AI models and human physicians in diagnosing rare diseases. Across 6,401 cases covering 2,919 rare conditions, it achieved a...

By SENS Research Foundation – The SENSible Blog
Most Health Systems Stall Patients' HIPAA Record Rights
SocialFeb 20, 2026

Most Health Systems Stall Patients' HIPAA Record Rights

HIPAA guarantees patients a right to their own medical records. In practice, most health systems require patients to fill out a release-of-information form designed for a different legal purpose; justify why they want their own data; and wait. I sampled...

By Josh Mandel, MD
Single Yes-or-No Question May Screen for Low Vision
NewsFeb 20, 2026

Single Yes-or-No Question May Screen for Low Vision

A study published in Investigative Ophthalmology & Visual Science shows that a single yes‑or‑no question can reliably screen for low vision and legal blindness, achieving area‑under‑the‑curve (AUC) values of 0.81 and 0.77 respectively. Researchers tested 385 adults across four U.S....

By Healio
How Oura Is Bringing Its Story to the Olympics
NewsFeb 20, 2026

How Oura Is Bringing Its Story to the Olympics

Oura Ring has been named the official wearable for Team USA at the Milan‑Cortina Winter Olympics, providing athletes and medical staff with real‑time sleep, recovery and metabolic data. The partnership, which also covers all Olympic and Paralympic athletes through the...

By Chief Marketer
Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy
SocialFeb 20, 2026

Cyborg Islet-Cell Implant Boosts Precision Diabetes Therapy

A cyborg pancreatic islet-cell implant takes the stem cell strategy to a new level of precision and potential future therapy for T1 diabetes @ScienceMagazine https://t.co/gkmsrzU1e4 https://t.co/qgegRPlEIl

By Eric Topol
AI-Based Platform Supports Community Health Workers in Street Medicine Program
NewsFeb 20, 2026

AI-Based Platform Supports Community Health Workers in Street Medicine Program

Akido Labs has deployed an AI‑native platform that equips community health workers with real‑time data collection, documentation, and patient‑engagement tools for street‑medicine teams. The model aligns with California’s CalAIM whole‑person care framework and shifts the heavy reporting burden away from...

By Healthcare Innovation
Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments
NewsFeb 20, 2026

Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments

CRM migrations in healthcare and life sciences are accelerating amid tighter regulations such as HIPAA, GDPR, and FDA 21 CFR Part 11. Avenga’s Roman Bevz outlines a compliance‑by‑design methodology that starts with mapping data to regulatory obligations and proceeds through risk analysis,...

By MedCity News
Senseonics Launches Automated Insulin Dosing System with 1-Year CGM
NewsFeb 20, 2026

Senseonics Launches Automated Insulin Dosing System with 1-Year CGM

Senseonics and Sequel Med Tech have launched an automated insulin‑delivery system that pairs the year‑long Eversense 365 implantable CGM with Sequel’s twiist pump. The integration, delayed to Q4 2025, marks the first AID solution using a one‑year sensor, contrasting with competitors’ 15‑day...

By MedTech Dive
AI in Cardiovascular Imaging and Interventions: Boon or Bane?
NewsFeb 20, 2026

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

At the 2026 EAPCI Summit, experts highlighted AI’s expanding role in cardiovascular interventions, from mortality risk modeling to intravascular imaging analysis. A University of Galway study identified gamma‑glutamyl transferase as a strong 10‑year mortality predictor in the SYNTAX cohort, validated...

By TCTMD
A Quercetin Nanocarrier‐Loaded Dual Network Injectable Hydrogel for Mesenchymal Stem Cells (MSCs) Delivery Targeting Osteoarthritis
NewsFeb 20, 2026

A Quercetin Nanocarrier‐Loaded Dual Network Injectable Hydrogel for Mesenchymal Stem Cells (MSCs) Delivery Targeting Osteoarthritis

Researchers have created an injectable dual‑network hydrogel composed of gelatin methacrylate and κ‑carrageenan that embeds quercetin‑loaded PLGA nanoparticles for mesenchymal stem cell (MSC) delivery in osteoarthritis (OA). The antioxidant hydrogel scavenges reactive oxygen species, reprograms M1 macrophages to an anti‑inflammatory...

By Small (Wiley)
Ready to Grow Your Surgery Center Without Losing Your Sanity
NewsFeb 20, 2026

Ready to Grow Your Surgery Center Without Losing Your Sanity

Surgery centers are expanding rapidly, but growth brings regulatory, staffing, and technology challenges that can overwhelm internal teams. Without a structured plan, new service lines often trigger credentialing, supply chain, and workflow gaps, leading to delays and cost overruns. Ambulatory...

By Health Tech Digital (UK)
To Streamline Workflows, Listen to Clinicians
NewsFeb 20, 2026

To Streamline Workflows, Listen to Clinicians

Chief Clinical Officer Dr. Michael Zappa of Cape Fear Valley Health, also a physician advisor at Juno Health, urges healthcare leaders to directly ask clinicians which administrative duties pull them away from patient care. He recommends mapping these tasks and...

By Healthcare Finance News (HIMSS Media)
Nanozyme Aptasensor: A Breakthrough in S. Aureus Diagnostics
NewsFeb 20, 2026

Nanozyme Aptasensor: A Breakthrough in S. Aureus Diagnostics

Researchers have unveiled a nanozyme‑aptamer colorimetric array that classifies Staphylococcus aureus strains with 100% accuracy, including methicillin‑resistant variants. The platform couples gold‑nanoparticle nanozymes with four strain‑specific aptamers, producing distinct color fingerprints that are decoded by hierarchical clustering and linear discriminant...

By AZoNano
Nobody Gets Sued but the Doctor: The Legal Vacuum at the Center of the AI Physician Revolution
BlogFeb 20, 2026

Nobody Gets Sued but the Doctor: The Legal Vacuum at the Center of the AI Physician Revolution

The episode examines the legal vacuum surrounding AI‑assisted clinical decision‑making, highlighting that while the FDA has cleared over 1,300 AI medical devices, adoption remains low and physicians bear virtually all malpractice liability. Data shows a rapid rise in AI use...

By Thoughts on Healthcare Markets & Tech
Kontakt.io Unveils Next-Generation AI Solutions to Re-ViVE Care Operations and Transform Healthcare Delivery
NewsFeb 20, 2026

Kontakt.io Unveils Next-Generation AI Solutions to Re-ViVE Care Operations and Transform Healthcare Delivery

Kontakt.io announced a suite of AI‑driven agents at ViVE 2026, combining real‑time location services (RTLS) with electronic health record data to create a digital twin of hospital operations. The portfolio—Patient Journey Analytics, Access Agent, Patient Flow Agent, and Supply Chain...

By AiThority
Pontiro Secures £357,500 to Expand Healthcare AI Infrastructure
NewsFeb 20, 2026

Pontiro Secures £357,500 to Expand Healthcare AI Infrastructure

Pontiro, a health‑tech firm that streamlines medical‑image data for AI, secured £357,500 in a round led by SFC Capital with participation from Plug and Play Ventures and the British Business Bank. The company’s platform has already processed more than two...

By Tech.eu
Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion
BlogFeb 20, 2026

Pharma Pulse: J&J’s $1B Cell Therapy Hub and Hims & Hers’ Global Expansion

Johnson & Johnson announced a $1 billion investment to build a next‑generation cell‑therapy manufacturing facility in Montgomery County, Pennsylvania, slated to support 500 skilled jobs. The hub is a key element of J&J’s $55 billion U.S. manufacturing, R&D, and technology strategy. Meanwhile,...

By Pharmaceutical Commerce (independent trade)
En Carta Diagnostics Receives FDA Breakthrough Device Designation for EC Pocket Lyme Test
NewsFeb 20, 2026

En Carta Diagnostics Receives FDA Breakthrough Device Designation for EC Pocket Lyme Test

En Carta Diagnostics announced that its EC Pocket Lyme test has received FDA Breakthrough Device Designation, accelerating its path to U.S. market entry. The point‑of‑need molecular assay detects Borrelia DNA directly from skin interstitial fluid using a microneedle sampler, delivering...

By Health Tech Digital (UK)
AngioDynamics Expands European Indications for NanoKnife System
NewsFeb 20, 2026

AngioDynamics Expands European Indications for NanoKnife System

AngioDynamics announced that its NanoKnife system now holds European CE‑mark indications for soft‑tissue ablation of liver, kidney, prostate and pancreas tumours, including intermediate‑risk prostate cancer. The device uses irreversible electroporation (IRE), a non‑thermal technology that destroys cancer cells while sparing...

By Hospital Management
4.2m Eye Health Research Hub Set for North East
BlogFeb 20, 2026

4.2m Eye Health Research Hub Set for North East

A £4.2 million Northern Ophthalmic Research and Innovation Institute (NORI) is being established in North East England to turn routine eye scans into early‑warning tools for serious illnesses. The hub, hosted by the University of Sunderland, will link eye images with...

By Health Tech World
Leica Launches CM1950 Cryostat with DualEcoTec Cooling System
NewsFeb 20, 2026

Leica Launches CM1950 Cryostat with DualEcoTec Cooling System

Leica Biosystems, a Danaher subsidiary, unveiled the Leica CM1950 cryostat equipped with DualEcoTec cooling. The device cools specimens up to three times faster and chambers up to twice as fast, slashing setup and case times. It employs a near‑zero global...

By Medical Design & Outsourcing
It’s Time for an End to Two-Tier Tech in the NHS
BlogFeb 20, 2026

It’s Time for an End to Two-Tier Tech in the NHS

The NHS is rapidly adopting AI and patient‑facing tools, yet back‑office staff such as roster managers remain stuck with outdated systems. This digital divide fuels stress, mismatched rotas, and higher temporary‑staff costs, contributing to the wider retention crisis. Trusts that...

By Journal of mHealth
Smart Insole to Predict and Prevent Elderly Falls
NewsFeb 20, 2026

Smart Insole to Predict and Prevent Elderly Falls

University of Bristol engineer Dr. Jiayang Li has created a smart shoe insole equipped with 253 micro‑sensors that map pressure and gait in real time. The device consumes only 100 microwatts, enabling up to three months of operation on a...

By UKAuthority (UK)
Grail's Cancer Test Misses Primary Study Goal in UK Study
NewsFeb 20, 2026

Grail's Cancer Test Misses Primary Study Goal in UK Study

Grail announced that its Galleri multi‑cancer blood test failed to achieve the primary endpoint in a large United Kingdom clinical trial. The study, which evaluated the test’s ability to detect early‑stage cancers across dozens of tumor types, showed promising signals...

By Endpoints News
Pison Perform Review After 515 Tests: This Wearable Tracks Brain Health, Reaction Time, & Decision Speed
BlogFeb 20, 2026

Pison Perform Review After 515 Tests: This Wearable Tracks Brain Health, Reaction Time, & Decision Speed

Pison Perform is a wrist‑worn wearable that uses medical‑grade electroneurography (ENG) to capture brain‑derived signals and deliver daily scores on reaction time, inhibition control, and sustained focus. After six months of testing, the reviewer recorded a 41.5 ms readiness gain and...

By Outliyr — High Performance Longevity
Electronic Mesh Spurs Islet Cell Maturation, Could Aid Diabetes Care
NewsFeb 20, 2026

Electronic Mesh Spurs Islet Cell Maturation, Could Aid Diabetes Care

Researchers at the University of Pennsylvania and Harvard have created an ultrathin, flexible electronic mesh that can be implanted into developing pancreatic tissue. The mesh delivers a 24‑hour rhythmic electrical pulse, coaxing stem‑cell‑derived islet cells toward functional maturity and synchronized...

By GEN (Genetic Engineering & Biotechnology News)
Combining PET and MRI Data May Be Key to Differentiating New Type of Dementia
NewsFeb 20, 2026

Combining PET and MRI Data May Be Key to Differentiating New Type of Dementia

Researchers have demonstrated that combining 18F‑FDG PET with high‑resolution MRI can reliably separate limbic‑predominant age‑related TDP‑43 encephalopathy (LATE) from Alzheimer’s disease in living patients. By creating stereotactic surface projection PET templates from autopsy‑confirmed cases and integrating MRI volumetry, the team...

By Radiology Business
Utah Launches State-Approved AI Prescription Refill Pilot as States Expand Health AI Oversight
NewsFeb 20, 2026

Utah Launches State-Approved AI Prescription Refill Pilot as States Expand Health AI Oversight

Utah’s Department of Health has green‑lit a 12‑month pilot that lets an approved artificial‑intelligence system automatically process prescription refills for chronic medications. The AI checks dosage, patient history, and insurance eligibility before sending the order to participating pharmacies, aiming to...

By Telehealth.org News
ViVE
NewsFeb 19, 2026

ViVE

ViVE 2025 convened leading health‑tech innovators to examine how security, artificial intelligence and other emerging technologies are reshaping digital health. Speakers highlighted AI‑driven diagnostics, robust cybersecurity frameworks, and interoperable platforms as essential for scaling patient‑centric care. The event also showcased...

By HealthTech Magazine
'Digital Blood Testing' Now at Hand
NewsFeb 19, 2026

'Digital Blood Testing' Now at Hand

A collaborative team led by UNSW and Nutromics has demonstrated a wearable patch that continuously measures vancomycin levels using DNA‑based aptamer sensors. Published in Nature Biotechnology, the pilot trial showed the patch can track drug concentration in interstitial fluid, offering...

By MobiHealthNews (HIMSS Media)
STAT+: Key Study of Grail’s Cancer Detection Test Fails in Setback for Company
NewsFeb 19, 2026

STAT+: Key Study of Grail’s Cancer Detection Test Fails in Setback for Company

Grail’s multi‑cancer blood test Galleri failed to meet its primary endpoint in a large NHS‑partnered study, casting doubt on its early‑detection claims. The test, priced at $1,000, generated $136.8 million from 185,000 units sold in 2025 but remains unapproved by the...

By STAT (Biotech)
Galleri Test Misses Primary Goal, Shows Secondary Promise
SocialFeb 19, 2026

Galleri Test Misses Primary Goal, Shows Secondary Promise

A key study of $GRAL's Galleri test in the UK failed to reach its primary endpoint, but showed benefits on a secondary endpoint. Tell me what you all think. https://t.co/CDrvokqPop

By Matthew Herper
Chronilogix Integrates with Balance for Life to Expand AI-Driven Behavioral Health and Chronic Care Support
NewsFeb 19, 2026

Chronilogix Integrates with Balance for Life to Expand AI-Driven Behavioral Health and Chronic Care Support

Chronilogix announced an integration that embeds its AI‑powered coaching technology into the Balance for Life wellness app. The combined solution delivers on‑demand behavioral health support for depression, anxiety and stress, while also addressing chronic condition management. By offering 24/7 personalized...

By Digital Health Global
Dock Health Introduces Its Productivity Platform at Mayo Clinic to Modernize Operational Workflows
NewsFeb 19, 2026

Dock Health Introduces Its Productivity Platform at Mayo Clinic to Modernize Operational Workflows

Dock Health announced that its productivity platform is now deployed at Mayo Clinic to automate referral and specialty workflows across cardiovascular, e‑consult and contract programs. The solution creates structured, real‑time workflows that trigger when orders enter the EHR, automatically assigning...

By Digital Health Global
Heart Failure Company BioVentrix Files for IPO
NewsFeb 19, 2026

Heart Failure Company BioVentrix Files for IPO

BioVentrix, a Massachusetts medtech firm developing the Revivent heart‑failure system, filed an IPO prospectus on Feb. 12, targeting a Nasdaq listing under BVXX. The company estimates a $10 billion valuation in the U.S. and $16 billion globally. Revivent, a minimally invasive LV reconstruction...

By Cardiovascular Business
Meta Reportedly Releasing More Display Glasses, Health and AI-Focused Smartwatch Later This Year
NewsFeb 19, 2026

Meta Reportedly Releasing More Display Glasses, Health and AI-Focused Smartwatch Later This Year

Meta is set to revive its smartwatch project with a 2026 launch under the codename “Malibu 2.” The new device will prioritize health tracking and deep integration with Meta’s AI services, diverging from earlier Android‑based concepts. In parallel, Meta plans to...

By 9to5Google
GE HealthCare Nabs 3 Notable MRI FDA Clearances
NewsFeb 19, 2026

GE HealthCare Nabs 3 Notable MRI FDA Clearances

GE HealthCare announced FDA clearance for three next‑generation MRI products: the 1.5‑T Signa Sprint with Freelium, the 3‑T Signa Bolt, and the AI‑driven workflow platform Signa One. The Sprint uses a helium‑free magnet that consumes less than 1 % of traditional coolant, while the...

By Radiology Business
MIT Researchers Develop Miniaturized Breast Ultrasound Wearable
NewsFeb 19, 2026

MIT Researchers Develop Miniaturized Breast Ultrasound Wearable

MIT researchers have created a miniature ultrasound system roughly the size of a smartphone and costing about $300, capable of capturing real‑time three‑dimensional breast images. The device uses a square‑array probe with CODA geometry, reducing transducer elements from 1,024 to...

By Medical Design & Outsourcing
Amazfit Debuts T-Rex Ultra 2 Watch with Biotracking, 30-Day Battery
NewsFeb 19, 2026

Amazfit Debuts T-Rex Ultra 2 Watch with Biotracking, 30-Day Battery

Amazfit, Zepp Health’s flagship wearable brand, launched the T‑Rex Ultra 2, a rugged GPS smartwatch aimed at extreme‑environment users. The device combines comprehensive biotracking—heart rate, SpO₂, sleep, breathing, and stress metrics—with 30‑day battery life, 100‑metre water resistance, and a Low Temperature...

By MobiHealthNews (HIMSS Media)
How Health Systems Reduce the Strain of Documentation Burden
NewsFeb 19, 2026

How Health Systems Reduce the Strain of Documentation Burden

Health systems are turning to cloud‑based generative AI to slash documentation overload. City of Hope deployed HopeLLM, an agentic large‑language‑model platform that creates concise medical‑history summaries in minutes, freeing clinicians from nightly “pajama time.” Providence built Provaria on Azure, using...

By HealthTech Magazine
Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B
NewsFeb 19, 2026

Hims & Hers Acquires Australian Digital Health Eucalyptus for Up to $1.15B

Hims & Hers Health announced a definitive agreement to acquire Australian digital‑health firm Eucalyptus for up to $1.15 billion, with $240 million paid in cash and the balance structured as deferred and earn‑out payments. Eucalyptus, founded in 2019, serves more than 775,000...

By HIT Consultant
Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy
SocialFeb 19, 2026

Adding Fragmentomics Boosts GRAIL’s Multicancer Detection Accuracy

The most used multicancer early detection (MCED) blood test (liquid biopsy) uses methylation (GRAIL). But combining that with DNA fragmentomics, as reported today @NatureCancer, improves early detection https://t.co/VkNDR4XuW3

By Eric Topol
Caregivers Find Much-Needed Relief with This Unique Eldercare Solution
NewsFeb 19, 2026

Caregivers Find Much-Needed Relief with This Unique Eldercare Solution

CareYaya, a student‑matching platform, connects college students with seniors and disabled adults to provide non‑medical in‑home assistance. By paying students directly at about $20 an hour, the service reduces care costs roughly 50 % compared with traditional agencies. The app’s algorithm...

By Employee Benefit News
MedStar Health, Withings Bring Connected Devices to Concierge Medicine Program
NewsFeb 19, 2026

MedStar Health, Withings Bring Connected Devices to Concierge Medicine Program

MedStar Health is scaling its Signature concierge primary‑care program by partnering with Withings Health Solutions to supply patients with cellular blood‑pressure cuffs and scales. The collaboration leverages MedStar’s existing telehealth and remote‑patient‑monitoring infrastructure to collect real‑world physiologic data outside the...

By Healthcare Innovation
Tech Fails in Fee‑For‑Service, Aledade Shows Value‑Based Solution
SocialFeb 19, 2026

Tech Fails in Fee‑For‑Service, Aledade Shows Value‑Based Solution

What happens when you drop great tech into a fee-for-service system? Farzad Mostashari has a blunt answer—and it’s worth hearing. See what Aledade is doing to make the math work for value-based care: https://t.co/iMKzsdQSrl @AledadeACO #ValueBasedCare #HITsm https://t.co/lL49Ha2UHC

By Colin Hung
Altera Digital Health Names Sean Sykes as Executive Vice President for Ventus
NewsFeb 19, 2026

Altera Digital Health Names Sean Sykes as Executive Vice President for Ventus

Altera Digital Health announced the appointment of Sean Sykes as Executive Vice President for its Ventus portfolio, which delivers integrated revenue cycle and administrative solutions. Sykes brings more than 20 years of experience building high‑performing sales and customer‑success teams in...

By Digital Health Global
Triplemoon Appoints Dr. Caroline Carney, CEO of Magellan Health, to Board of Directors
NewsFeb 19, 2026

Triplemoon Appoints Dr. Caroline Carney, CEO of Magellan Health, to Board of Directors

Triplemoon announced that Dr. Caroline Carney, CEO of Magellan Health and dual board‑certified psychiatrist‑internist, has joined its Board of Directors. The appointment coincides with a $3.5 million seed round led by Activate Venture Partners and LiveOak Ventures aimed at scaling its...

By Digital Health Global
Medtronic’s RDN System Receives New Reimbursement Approval
NewsFeb 19, 2026

Medtronic’s RDN System Receives New Reimbursement Approval

Medtronic’s Symplicity Spyral renal denervation system has secured reimbursement approval from Japan’s Ministry of Health, Labour and Welfare, expanding coverage for resistant hypertension. The therapy, which uses radio‑frequency energy to ablate renal nerves via a single catheter, was previously approved...

By Cardiovascular Business